MARKET

RXST

RXST

Rxsight, Inc.
NASDAQ
12.63
+0.14
+1.12%
After Hours: 12.63 0 0.00% 17:01 12/05 EST
OPEN
12.53
PREV CLOSE
12.49
HIGH
13.16
LOW
12.47
VOLUME
797.59K
TURNOVER
--
52 WEEK HIGH
46.77
52 WEEK LOW
6.32
MARKET CAP
519.30M
P/E (TTM)
-14.3817
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RXST last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at RXST last week (1117-1121)?
Weekly Report · 11/24 09:03
Ross Stores Posts Strong Q3 Results, Joins Enviri, Azenta And Other Big Stocks Moving Higher On Friday
Benzinga · 11/21 16:14
RxSight Inc. to Present at Piper Sandler Healthcare Conference
Reuters · 11/20 21:05
Weekly Report: what happened at RXST last week (1110-1114)?
Weekly Report · 11/17 09:03
Weekly Report: what happened at RXST last week (1103-1107)?
Weekly Report · 11/10 09:03
RxSight Earnings Call: Mixed Signals Amid Growth and Challenges
TipRanks · 11/07 01:08
RxSight Is Maintained at Underweight by JP Morgan
Dow Jones · 11/06 22:13
More
About RXST
RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.

Webull offers Rxsight Inc stock information, including NASDAQ: RXST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RXST stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RXST stock methods without spending real money on the virtual paper trading platform.